Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsNov 16 05:32 · Ratings

Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)

TipRanksNov 16 04:35

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaNov 15 05:10

Express News | Adial Pharmaceuticals Inc - Study Completion Satisfies FDA Requirement for Phase 3 Trials

BreakingsNov 14 21:30

Adial Pharmaceuticals Announces Positive Topline Results From the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

GlobeNewswireNov 14 21:30

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

BenzingaNov 14 21:00